Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022.

Rome, Benjamin N; Nagar, Sarosh; Egilman, Alexander C; Wang, Junyi; Feldman, William B; Kesselheim, Aaron S

Rome, Benjamin N; Nagar, Sarosh; Egilman, Alexander C; Wang, Junyi; Feldman, William B; Kesselheim, Aaron S.

Afiliação

Rome BN; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Nagar S; Harvard Medical School, Boston, Massachusetts.
Egilman AC; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Wang J; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Feldman WB; Harvard Medical School, Boston, Massachusetts.
Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

JAMA Health Forum ; 4(1): e225218, 2023 01 06.

Article em En | MEDLINE | ID: mdl-36705916

Assuntos

Medicare Part B; Medicamentos sob Prescrição; Estados Unidos; Negociação; Estudos Transversais; Custos de Medicamentos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicare Part B / Medicamentos sob Prescrição Tipo de estudo: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies País/Região como assunto: America do norte Idioma: En Revista: JAMA Health Forum Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google